146 related articles for article (PubMed ID: 26792865)
1. Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment.
Dăneasă A; Cucolaş C; Lenghel LM; Olteanu D; Orăsan R; Filip GA
Reproduction; 2016 Apr; 151(4):401-9. PubMed ID: 26792865
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats.
Dikmen A; Ergenoglu AM; Yeniel AO; Dilsiz OY; Ercan G; Yilmaz H
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):55-9. PubMed ID: 22071112
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M
Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone and dimethylsulfoxide effect on glucose metabolism and oxidative stress markers in polycystic ovarian syndrome rat model.
Dăneasă A; Cucolaș C; Furcea M; Bolfa P; Dudea S; Olteanu D; Alupei MC; Mureșan A; Filip GA
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):154-62. PubMed ID: 24643692
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat.
Pandey V; Singh A; Singh A; Krishna A; Pandey U; Tripathi YB
Reprod Biol; 2016 Mar; 16(1):70-7. PubMed ID: 26952756
[TBL] [Abstract][Full Text] [Related]
6. Altered vitamin D
Grzesiak M; Burzawa G; Kurowska P; Blaszczyk K; Szlaga A; Blasiak A; Sechman A; Rak A
Histochem Cell Biol; 2021 Jan; 155(1):101-116. PubMed ID: 33095902
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T
J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of isoflavone-aglycone fraction from soybean (
Alivandi Farkhad S; Khazali H
Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary.
Rezvanfar MA; Saadat S; Shojaei Saadi HA; Mansoori P; Saeedi S; Gooshe M; Baeeri M; Abdollahi M
Theriogenology; 2015 Apr; 83(6):968-77. PubMed ID: 25557188
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Rajan RK; M SS; Balaji B
Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
12. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome.
Kabel AM; Al-Shehri AH; Al-Talhi RA; Abd Elmaaboud MA
Chem Biol Interact; 2017 Aug; 273():190-199. PubMed ID: 28619389
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.
Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M
Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Shojaei-Saadi HA; Baeeri M; Abdollahi M
Theriogenology; 2012 Aug; 78(3):620-31. PubMed ID: 22541319
[TBL] [Abstract][Full Text] [Related]
15. Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
Bulut G; Kurdoglu Z; Dönmez YB; Kurdoglu M; Erten R
Int J Clin Exp Pathol; 2015; 8(8):8774-85. PubMed ID: 26464620
[TBL] [Abstract][Full Text] [Related]
16. The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.
Hong Y; Yin Y; Tan Y; Hong K; Zhou H
Med Sci Monit; 2019 Jan; 25():395-401. PubMed ID: 30636259
[TBL] [Abstract][Full Text] [Related]
17. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
Patel R; Shah G
Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
[TBL] [Abstract][Full Text] [Related]
18. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.
Mesbah F; Moslem M; Vojdani Z; Mirkhani H
J Ovarian Res; 2015 Nov; 8():74. PubMed ID: 26577050
[TBL] [Abstract][Full Text] [Related]
19. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
20. Central leptin resistance and hypothalamic inflammation are involved in letrozole-induced polycystic ovary syndrome rats.
Lian Y; Zhao F; Wang W
Biochem Biophys Res Commun; 2016 Aug; 476(4):306-312. PubMed ID: 27233601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
